Status:
COMPLETED
Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant
Lead Sponsor:
National Hepatology & Tropical Medicine Research Institute
Conditions:
Liver Transplant Infection
Eligibility:
All Genders
18-70 years
Brief Summary
, the study aimed at assessing the frequency of rising procalcitonin associated with infectious complications in immunosuppressed LDLTRx.
Detailed Description
All patients transferred from operative theatre to ICU will be sedated, intubated \& ventilated. They will receive empiric antimicrobial prophylaxis upon admission \& early immunosuppression according...
Eligibility Criteria
Inclusion
- including adult patients aged ≥18 years old who are recipients for living donated liver transplantation (LTx) at the Department of Liver Transplant of National Hepatology \& Tropical Medicine Research Institute (NHTMRI), between January 2014 and January 2018 \& with no contraindications for early immunosuppression.
Exclusion
- Patients will be excluded from the study if they are readmitted or had primary graft nonfunction.
Key Trial Info
Start Date :
March 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03389360
Start Date
March 15 2018
End Date
February 10 2019
Last Update
March 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NHTMRI
Cairo, Egypt